The absolute bioavailability and lung tissue distribution of the triamilide antimicrobial, tulathromycin, were investigated in swine. Fifty-six pigs received 2.5 mg/kg of tulathromycin 10% formulation by either intramuscular (i.m.) or intravenous (i.v.) route in two studies: study A (10 pigs, i.m. and 10 pigs, i.v.) and study B (36 pigs, i.m.). After i.m. administration the mean maximum plasma concentration (Cmax) was 616 ng/mL, which was reached by 0.25 h postinjection (tmax). The mean apparent elimination half-life (t1/2) in plasma was 75.6 h. After i.v. injection plasma clearance (Cl) was 181 mL/kg·h. the volume of distribution at steady-state (Vss) was 13.2 L/kg and the elimination t1/2 was 67.5 h. The systemic bioavailability following i.m. administration was >87% and the ratio of lung drug concentration for i.m. vs. i.v. injection was >0.96. Following i.m. administration, a mean tulathromycin concentration of 2840 ng/g was detected in lung tissue at 12 h postdosing. The mean lung C max of 3470 ng/g was reached by 24 h postdose (tmax). Mean lung drug concentrations after 6 and 10 days were 1700 and 1240 ng/g, respectively. The AUCinf was 61.4 times greater for the lung than for plasma. The apparent elimination t1/2 for tulathromycin in the lung was 142 h (6 days). Following i.m. administration to pigs at 2.5 mg/kg body weight, tulathromycin was rapidly absorbed and highly bioavailable. The high distribution to lung and slow elimination following a single dose of tulathromycin, are desirable pharmacokinetic attributes for an antimicrobial drug indicated for the treatment of respiratory disease in swine.
CITATION STYLE
Benchaoui, H. A., Nowakowski, M., Sherington, J., Rowan, T. G., & Sunderland, S. J. (2004). Pharmacokinetics and lung tissue concentrations of tulathromycin in swine. Journal of Veterinary Pharmacology and Therapeutics, 27(4), 203–210. https://doi.org/10.1111/j.1365-2885.2004.00586.x
Mendeley helps you to discover research relevant for your work.